Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Inventory Average (2016 - 2025)

Historic Inventory Average for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to $188.8 million.

  • Amphastar Pharmaceuticals' Inventory Average rose 4943.52% to $188.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.8 million, marking a year-over-year increase of 4943.52%. This contributed to the annual value of $129.8 million for FY2024, which is 2395.08% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Inventory Average is $188.8 million, which was up 4943.52% from $188.6 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Inventory Average peaked at $188.8 million during Q3 2025, and registered a low of $94.0 million during Q1 2022.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Inventory Average value was $104.1 million (recorded in 2023), while the average stood at $118.6 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Inventory Average crashed by 1119.96% in 2021 and then soared by 5855.36% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Inventory Average (Quarter) stood at $96.5 million in 2021, then grew by 7.14% to $103.4 million in 2022, then rose by 4.34% to $107.9 million in 2023, then surged by 31.62% to $142.0 million in 2024, then surged by 32.95% to $188.8 million in 2025.
  • Its Inventory Average was $188.8 million in Q3 2025, compared to $188.6 million in Q2 2025 and $169.6 million in Q1 2025.